Positron Corporation Stock

Equities

POSC

US7373976049

Advanced Medical Equipment & Technology

Market Closed - OTC Markets 02:34:31 2024-05-01 pm EDT 5-day change 1st Jan Change
1.1 USD 0.00% Intraday chart for Positron Corporation -4.35% -29.94%
Sales 2013 1.63M Sales 2014 1.47M Capitalization 7.26M
Net income 2013 -7M Net income 2014 -2M EV / Sales 2013 6.92 x
Net Debt 2013 4.31M Net Debt 2014 862K EV / Sales 2014 5.54 x
P/E ratio 2013
-0.98 x
P/E ratio 2014
-1.86 x
Employees 19
Yield 2013 *
-
Yield 2014
-
Free-Float 95.99%
More Fundamentals * Assessed data
Dynamic Chart
1 week-4.35%
Current month-10.57%
1 month+6.80%
3 months-22.10%
6 months-12.00%
Current year-29.94%
More quotes
1 week
1.10
Extreme 1.1
1.30
1 month
1.03
Extreme 1.03
1.30
Current year
1.00
Extreme 1
1.60
1 year
0.87
Extreme 0.87
1.97
3 years
0.07
Extreme 0.0682
2.25
5 years
0.00
Extreme 0
2.25
10 years
0.00
Extreme 0
3.60
More quotes
Managers TitleAgeSince
President 51 -
Chief Administrative Officer - -
Sales & Marketing - 22-06-23
Members of the board TitleAgeSince
President 51 -
Director/Board Member - -
More insiders
Date Price Change Volume
24-05-01 1.1 0.00% 350
24-04-30 1.1 0.00% 7,843
24-04-29 1.1 -4.35% 2,257
24-04-26 1.15 -8.00% 779
24-04-24 1.25 +8.70% 3,141

Delayed Quote OTC Markets, May 01, 2024 at 02:34 pm EDT

More quotes
Positron Corporation is a molecular imaging device company, which offers a positron emission tomography (PET) imaging system and clinical services to nuclear medicine healthcare providers throughout North America. The Company is specialized in the field of cardiac PET imaging, the gold standard in cardiac diagnostics. Its PET technology, clinical services and imaging practice solutions enables healthcare providers to diagnose coronary artery disease and improve patient outcomes through providing medicine. It offers nuclear cardiologists its Attrius PET nuclear imaging device, technical and clinical services, and can provide financing solutions to meet the needs of hospitals and medical imaging practices. Its products and services enables healthcare providers to diagnose CAD and improve patient outcomes.
More about the company